-
Symbol
-
BTAI on Nasdaq
-
Investment type
-
Equity - Shares of Stock
-
Class
-
Common Stock, par value $0.001 per share
-
Latest Disclosed Ownership
-
2.72M shares
-
Security Ownership
-
5.2%
Oaktree Capital Group Holdings GP, LLC ownership in BioXcel Therapeutics, Inc. Common Stock, par value $0.001 per share (BTAI)
2024-12-18 - Oaktree Capital Group Holdings GP, LLC has filed an SCHEDULE 13G form with the Securities and Exchange Commission (SEC) disclosing ownership of 2.72M shares of BioXcel Therapeutics, Inc. Common Stock, par value $0.001 per share (BTAI).
This represents 5.2% percent ownership of the company.